[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:hla-b-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"HLA-B Gene",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT03943238","TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation",[11],"Phase 1","RECRUITING","2026-08-26T02:16:47.762107Z","2026-07-05T03:45:20.247624Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06315309","Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant",[19],"Phase 2","2026-08-26T02:16:48.735701Z","2026-05-05T02:43:29.662218Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT06741072","BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants",[11],"2026-08-26T02:18:15.214990Z","2026-07-05T03:45:20.248647Z"]